|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
||||
 |
|||
Latest News: ... Latest Story Further Information: UMIP - Case Studies of Spin-outs
UPF Masterclasses: December 1st 2009 March 31st 2009 November 25th 2008 UPF Masterclass Hall of Fame |
05/08/10 MTI Investee APATECH wins prestigious Large Deal of the Year award at 2010 Vitesse Media Awards 24/05/10 UPF increases investment in Arvia Technology 12/05/10 UPF Invests in University of Manchester med-tech spin-out, BiOxyDyn 28/04/10 UPF leads £1.15m investment round in PowerOasis 01/03/10 MTI has largest ever exit by selling investee company APATECH for $330m 22/02/10 Ai2 Limited announce appointment of new CEO 18/02/10 Nano ePrint partners with Novalia to deliver printed electronic greeting cards for Tigerprint 03/02/10 UPF leads £2m investment round to help bring new pest control products to market 23/01/10 UPF investee MYCONOSTICA launches Pneumocystis diagnostic kit in Europe and Canada 22/01/10 14/01/10 NWDA awards £9m Transitional fund to MTI 30/11/09 MTI & NWDA boosts Manchester hi-tech spin-out 13/11/09 Award winning week for the UMIP Premier Fund’s investments 26/10/09 22/10/09 UPF Invests half a million in CABLESENSE - North West hi-tech specialists back Lancaster busines 07/09/09 UPF Investee MYCONOSTICA attracts £1.7m in Series D financing to progress its fungal diagnostics 05/09/09 UPF Investee ARVIA TECHNOLOGY named in Global Cleantech 100 company listing 05/09/09 ‘Proud parents’ celebrate 25th birthday of breakthrough technology 09/07/09 UPF Investee ARVIA TECHNOLOGY wins major North West Innovation award 29/06/09 UMIP scoops Business Impact Award 19/03/09 Breakthrough research by University student could speed up the recovery of injured athletes. |
It has been an award winning week for two UMIP Premier Fund investments. Manchester based Renephra and Myconostica, are part of the UMIP Premier Fund which is managed by technology specialists MTI Partners, who invest in hi-tech, high growth companies. Myconostica was awarded the ‘Innovation in Diagnostics Project of the Year’, at this year’s Northwest Biomedical Awards dinner, whilst Renephra received the ‘Emerging Technology Project of the Year’ at the same ceremony, but also scooped a ‘Northwest NHS Innovations Award’ at a separate event. University of Manchester School of Medicine spin out, Myconostica, is a medical diagnostic company which develops and commercialises rapid and highly specific tests for life-threatening fungal infections. The award was received for Myconostica’s MycArray Yeast ID product; an inventive system for identifying Candida species. Renephra, also a spin out project from The University of Manchester and the Central Manchester University Hospitals NHS Foundation Trust, were recognised for the development of their groundbreaking fluid removal technology that could dramatically improve the quality of life of patients with kidney disease and improve their long term prognosis. Dr. John Thornback, Myconostica’s Chief Operating Officer, received the honour on behalf of the company at the award ceremony. Speaking at the event, Dr. Thornback said “Myconostica is delighted to have received this title in recognition of the innovative technology utilised in our original test for identifying Candida species, MycArray Yeast ID. Dr. Thornback continues: “Having been the recipients of Bionow’s Biomedical Start Up of the Year Award in 2006 we are delighted to have been further recognised for our continued contribution to providing innovative diagnostic solutions for the treatment of invasive fungal diseases.” Renephra’s Prof. Paul Brenchley said: “Receiving one award is fantastic, so to have our technology recognised by both the Northwest NHS Innovations Award and the Northwest Biomedical Awards in one week is a huge honour.” Manchester based MTI Partners Investment Manager Mark Rahn said: “I am delighted that the University of Manchester and NHS projects have featured so well in recent awards events. MTI’s UMIP Premier Fund is a supporter of both Myconostica and Renephra and we are pleased that these awards recognise their recent strides forward.” www.myconostica.com |
|
|
|
|
|
 |
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
|